NCPIE, Copyright 2007 Written Drug Information: Now & into the Future A look at where things now stand with the provision of useful written information.

Slides:



Advertisements
Similar presentations
Prescription Drug Information for Consumers and Healthcare Professionals 48 th FDLI Annual Meeting Washington, DC Wm. Ray Bullman Executive Vice President.
Advertisements

WPA-WHO Global Survey of Psychiatrists' Attitudes Towards Mental Disorders Classification Results for the Spanish Society of Psychiatry.
Pharmacology and the Nursing Process in LPN Practice
1 January 5, 2014 ©Copyright 2010 Jacqueline Madrigal Benefits Manager.
Stop. Think. Connect. National Cybersecurity Awareness Campaign October 2010.
[Imagine School at North Port] Oral Exit Report Quality Assurance Review Team School Accreditation.
Ten years of the CHD NSF Professor Roger Boyle CBE National Director for Heart Disease and Stroke Department of Health.
Slide 1 FastFacts Feature Presentation January 15 th, 2009 We are using audio during this session, so please dial in to our conference line… Phone number:
Enhancing Written Information from the Pharmacy: An Update on MedGuides & Consumer Medicine Information (CMI) National Association of Chain Drug Stores.
FDA Safe Use Initiative Public Meeting REDUCING UNINTENDED ACETAMINOPHEN OVERDOSE Strategic Integration of Acetaminophen Safe Use Content into NCPIE Web.
Educate Before You Medicate: A Big Picture Look at Adherence Improvement Ray Bullman Executive Vice President National Council on Patient Information and.
Labeling Prescription Drugs for Physicians and Consumers 48 th Annual Conference Preparing for the Next Century of Food and Drug Regulation Food and Drug.
Drug Information for Consumers and Healthcare Professionals Food and Drug Law Institute Annual Meeting Alan Goldhammer, PhD Associate VP Regulatory Affairs.
NCPIE CMI Initiative. Education Committee Members American Pharmacists Association First DataBank National Assn. of Boards of Pharmacy National Assn.
NCPIE CMI Initiative. Goals Letter of the Law –Fulfill promise of the Keystone process Spirit of the Law –Provide useful information for low literate.
NCPIE CMI Initiative. Implementation Cmte. Members American Society for Automation in Pharmacy Catalina Marketing Merck Research Labs National Community.
ASAP 2011 Annual Industry & Technology Issues Conference On the Same Page? FDA, Brookings Institution and the Quest for a Single-Document Solution for.
Collegiate Prescription Drug Abuse Prevention Conference The Ohio State University August 8, 2012 Ray Bullman National Council on Patient Information and.
Ray Bullman, Executive Vice President National Council on Patient Information and Education USP Label Standards Update & FDA Patient Medication Information.
Disability status in Ethiopia in 1984, 1994 & 2007 population and housing sensus Ehete Bekele Seyoum ESA/STAT/AC.219/25.
Integrating the NASP Practice Model Into Presentations: Resource Slides Referencing the NASP Practice Model in professional development presentations helps.
DIVERSE COMMUNITIES, COMMON CONCERNS: ASSESSING HEALTH CARE QUALITY FOR MINORITY AMERICANS FINDINGS FROM THE COMMONWEALTH FUND 2001 HEALTH CARE QUALITY.
What is valorisation ? Growth €
NexSAT NexSAT Steering Group Meeting - 8 June 2004 © 2004 European Organisation for the Safety of Air Navigation (EUROCONTROL) 1 Welcome to the 4th meeting.
California Preschool Learning Foundations
DRDP Measure Slides by Domain
Illinois Department of Children and Family Services, Pathways to Strengthening and Supporting Families Program April 15, 2010 Division of Service Support,
HISPC-Illinois II The Public-Private Partnership Moves Forward on Privacy and Security.
Create an Application Title 1Y - Youth Chapter 5.
1 Advisory Council April 1, 2011 Child Care Development Fund – State Plan for Federal Fiscal Years 2012 and 2013.
1 EEC Board Meeting May 10, 2011 Child Care Development Fund – State Plan for Federal Fiscal Years 2012 and 2013.
PP Step in to Learning Improving the skills of parents and carers. Improving the skills of health professionals. A training and development programme for.
Supported by 1 1 kids learn from people who care welcome! velkomin!
1 According to PETROSAFE safety policy, the company is keen that: Introduction All Egyptian Petroleum companies and foreign companies working in A.R.E.
Break Time Remaining 10:00.
Presentation of the proposed Annex 19 – Safety Management
National Action Plan for Nursing & Midwifery 2002 – 2010 evaluation
1 Quality Indicators for Device Demonstrations April 21, 2009 Lisa Kosh Diana Carl.
Customer Service.
Scottish Intensive Care Society Audit Group, Annual Report Note from Scottish Intensive Care Society Audit Group.
1 NM Behavioral Health Collaborative New Mexico Behavioral Health Plan for Children, Youth and Their Families March 2007.
1 Medication Reconciliation at Osborne Park Hospital Karen Chapman, Senior Pharmacist Aaron Cook, SQuIRe Project Officer.
5th Annual PBM Pharmacy Informatics Conference
The Longevity Economy The Emerging Market in Plain Sight.
Promoting Regulatory Excellence Self Assessment & Physiotherapy: the Ontario Model Jan Robinson, Registrar & CEO, College of Physiotherapists of Ontario.
WHO update on: Guidelines for the selection of RH medicines and prequalification of priority RH medicines Medicines Policy and Standards Health Technology.
Advancing Patient Engagement through Coalition Partnerships 2nd Annual Optimizing Patient Adherence Conference Wm. Ray Bullman, M.A.M., Executive Vice.
Influencing Public Policy Bob Howard President, CIA Canadian experience.
TCCI Barometer September “Establishing a reliable tool for monitoring the financial, business and social activity in the Prefecture of Thessaloniki”
7/16/08 1 New Mexico’s Indicator-based Information System for Public Health Data (NM-IBIS) Community Health Assessment Training July 16, 2008.
Orientation to the Planning 10 IRP  How does Planning 10 fit into the 2004 Graduation Program?  How was Planning 10 developed?  What’s the difference.
1 Phase III: Planning Action Developing Improvement Plans.
PSSA Preparation.
Essential Cell Biology
05/19/04 1 A Lessons Learned Process Celebrate the Successes Learn From the Woes Natalie Scott, PMP Sr. Project Manager.
CT\Sept98\OPHS\MG-HealthyPeople p. 1 Comment on Healthy People 2010 Draft Objectives September 15 – December 15, healthypeople.
Presented to: By: Date: Federal Aviation Administration FAA Safety Team FAASafety.gov AMT Awards Program Sun ‘n Fun Bryan Neville, FAASTeam April 21, 2009.
PER UN PAESE MIGLIORE 21/22/23 OTTOBRE 2010 MOSTRA D’OLTREMARE/NAPOLI SECONDO CONGRESSO NAZIONALE DEI DOTTORI COMMERCIALISTI E DEGLI ESPERTI CONTABILI.
To Err Really is Human: Misunderstanding Medication Labels Terry C. Davis, PhD LSUHSC-S Ruth Parker, MD Emory University.
Presented by Margaret Shandorf
April 8, 2005FDLI Annual Conference 1 Labeling Prescription Drugs for Physicians and Consumers (FDA Perspective) Paul J. Seligman, MD, MPH Director, Office.
Prescription Drug Information for Patients: History
Accelerating Progress in Promoting Prescription Medicine Adherence: The Adherence Action Agenda Presented by: Ray Bullman National Council on Patient Information.
Generation Rx Collegiate Conference August 5-8, 2014 Ray Bullman National Council on Patient Information and Education (NCPIE) NCPIE Resources for Collegiate.
The 30 Minute BPMH Work Out: Tips, Tools and Strategies for Getting an Efficient and Complete Best Possible Medication History Olavo Fernandes BScPhm,
2 “The label is the most important product that a company’s research arm produces…” Essence of Licensure Conveys the Use of the Product Describes Efficacy.
1 Presentation of the Pharmaceutical Research and Manufacturers of America at FDA Part 15 Hearing on Communication of Drug Safety Information December.
History of FDA Consumer Information About Prescription Drugs Thomas J. McGinnis, R.Ph. July 17, 2002.
Canadian Best Practice Recommendations for Stroke Care Recommendation 1: Public Awareness and Patient Education (Updated 2008)
Useful Medication Information for Consumers Gerald K. McEvoy, Pharm.D. Assistant Vice President, Drug Information Editor in Chief, AHFS Drug Information.
Presentation transcript:

NCPIE, Copyright 2007 Written Drug Information: Now & into the Future A look at where things now stand with the provision of useful written information to consumers, along with some conjecture as to how the future of drug information might evolve. Ray Bullman Executive Vice President National Council on Patient Information and Education April 24, 2007

NCPIE, Copyright 2007 ABOUT NCPIE Produces messages & /materials to promote better consumer – patient – provider dialogue about medicines Sample Activities: National Brown Bag Medicine Review, Talk About Rx Month, Be MedWise about OTCs, Consumer Medicine Information (CMI) Initiative Written Drug Information: Now & into the Future

NCPIE, Copyright 2007 Written Drug Information: Now and Into the Future NCPIEs Role = Catalyst & Convener –Encourage committed stakeholders to meet long-range CMI goals established in Public Law , outlined in Action Plan for Provision of Useful Prescription Medicine Information –CMI Initiative formed March 2003

NCPIE, Copyright 2007 Written Information: Recent Regulatory History 1995: FDA proposed MedGuide Rule 1996: Public Law ; private sector charged with developing criteria for useful written medicine information (CMI) 1997: HHS Secretary accepts Action Plan; Targets set for 2000 & 2006; FDA = judge FDAs interim evaluation released June 2002

NCPIE, Copyright 2007 CMI Targets 95% - Distribution with new Rxs at retail pharmacies 95% -CMI leaflets that meet Agencys interpretation of Action Plan criteria as delineated in FDAs Guidance on Useful Written Consumer Medicine Information (July 2006)

NCPIE, Copyright 2007 NCPIE Involvement in Written Medicine Information 1996: NCPIE represented on Keystone Action Plan Committee (useful CMI) 97-00:NCPIE stakeholder conferences include Action Plan topics 2002:FDA encourages NCPIE to act as convener/catalyst to stimulate stakeholder activity to achieve Action Plan goals

NCPIE, Copyright 2007 NCPIE Involvement in Written Medicine Information July 02:NCPIE FDA mid- course assessment public hearing March 03: 1 st meeting of NCPIE CMI Initiative stakeholders, FDA, & Svarstad team March 04:NCPIE convenes all-hands stakeholder meeting w/FDA

NCPIE, Copyright 2007 NCPIE Involvement in Written Medicine Information June 04:NCPIE CMI Criteria Cmtee meets with FDA team & Svarstad Aug. 04: NCPIE Criteria Cmtee completes Guide for Assessing Usefulness of CMI Sept. 04:NCPIE submits Assessment Guide (above) to FDA for input. Oct. 04 – No Agency response on Assessment May 05:Guide

NCPIE, Copyright 2007 NCPIE Involvement in Written Medicine Information April 05:NCPIE organizes session on CMI, PhRMA Paperless Labeling Initiative & FDAs Daily Med & Medication Guide FDLI annual mtg. May 05:FDA publishes draft guidance on CMI

NCPIE, Copyright 2007 NCPIE Involvement in Written Medicine Information July 05:NCPIE submits comments to FDA docket on draft CMI guidance; re- submits CMI Assessment Guide Aug. 05:NCPIE submits comments to FDA docket on draft Guidance for Industry on FDAs Drug Watch for Emerging Drug Safety Information

NCPIE, Copyright 2007 NCPIE Involvement in Written Medicine Information July 06:FDA releases final Guidance on Useful Written CMI (14 months after release of draft guidance) July 06:NCPIE organizes telecon with FDA & three dozen stakeholder groups to provide opportunity for Q & A about final CMI guidance

NCPIE, Copyright 2007 NCPIE Involvement in Written Medicine Information MedGuides / e- MedGuides Jan. 05: FDA invites NCPIE to organize stakeholder discussions about Medication Guide dissemination; NCPIE helps organize 3 meetings: July 05 Oct. 05 Sept. 06

NCPIE, Copyright 2007 NCPIE: Catalyst for Stakeholder Meetings with FDA on MedGuides Sept Meeting with FDA: Key issues / recommendations from pharmacy supply chain paper presented Summary of NCPIE focus groups to assess consumers' views on CMI and MedGuides presented.

NCPIE, Copyright 2007 NCPIE Focus Groups -- Medication Guides -- -Focus group members appreciated formatted MedGuide more than unformatted CMI -MedGuide information should be provided by prescriber: *Best time for questions; too late at the pharmacy; *Can ask for alternative medicine

NCPIE, Copyright 2007 Key Issues Paper distribution = poor distribution process Pharmacists dont know about MedGuides Compliance with regulation (model pharmacy act) Content of MedGuides: variability; confusion due to quantity of information Integration of MG content into CMI Cost shift to pharmacy ?

NCPIE, Copyright 2007 Written Information: Questions to Ponder What impact will introduction of FDAs Patient Information Sheets (PIS) have: On stakeholders: publishers, systems vendors, printers, packagers, pharmacies, pharmacists, prescribers? On patients and caregivers?

NCPIE, Copyright 2007 Written Information: Questions to Ponder What impact will introduction of more and more Medication Guides have on CMI? - On stakeholders (publishers, systems vendors, pharmacies, pharmacists)? - On patients and caregivers?

NCPIE, Copyright 2007 Written Information: Questions to Ponder What do we know about consumers: –Reaction to CMI? (apart from what FDA says) –Use of CMI? –Expectations about or preferences for CMI?

NCPIE, Copyright 2007 Consumer Medicine Information (circa March 2004)

NCPIE, Copyright 2007

Action Plan Action Plan Compliant CMI (circa 2006)

NCPIE, Copyright 2007

2007 CMI Assessment Goal # 1 95% Distribution Very obtainable Low hanging fruit -- 11% of pharmacies that did not provide mid-point have had ample notification of deficiency Preference: include other dispensing sites as well as community pharmacies (e.g., mail order)

NCPIE, Copyright CMI Assessment Goal # 2 95% Useful CMI (per Action Plan and FDAs interpretive Final Guidance on criteria for content, design, layout, and readability) Full goal attainment much more challenging; At retail level – requires universal systems changes by 60,000+ community pharmacies in collaboration with 3rd party system vendors (from large chains to single pharmacy) At retail level –requires universal systems changes by 60,000+ community pharmacies in collaboration with 3rd party system vendors (from large chains to single pharmacy)At retail level –requires universal systems changes by 60,000+ community pharmacies in collaboration with 3rd party system vendors (from large chains to single pharmacy)

NCPIE, Copyright CMI Assessment Goal # 2 95% Useful CMI (per Action Plan and FDAs interpretive Final Guidance on criteria for content, design, layout, and readability) Publishers - content is compliant (self report); Publishers – content available in multiple formats (text, xml) Publishers - encouraging FDA to review / comment on monographs prior to dissemination (What role might state pharmacy boards play in CMI feedback / oversight?)

NCPIE, Copyright CMI Assessment Goal # 2 95% Useful CMI (per Action Plan and FDAs interpretive Final Guidance on criteria for content, design, layout, and readability) At the retail level –requires universal systems changes by 60,000+ pharmacies in collaboration with 3rd party system vendors (from large chains to single pharmacy) If publishers content revisions are indeed Action Plan compliant, challenge becomes roll-out / implementation, populating marketplace with new CMI

NCPIE, Copyright 2007 State of Flux / Whats in Play Goal # 2 95% Useful CMI (per Action Plan and FDAs interpretive Final Guidance on criteria for content, design, layout, and readability) Reluctance to commit $ / change in part due to state of flux related to dissemination of medicine information. Whats in play: –CMI (as we now know it) –Medication Guides (as we now know them)

NCPIE, Copyright 2007 Whats in Play? –Medication Guides( pdf format, capacity to produce e- version, in conjunction with CMI or stand-alone) –Package Insert (PI) - paper –e-Package Insert ( PhRMA Paperless Labeling ) –Patient Package Insert (PPI) - paper –DailyMed (FDA & Library of Medicine)

NCPIE, Copyright 2007 Whats In Play? ALL OF THE ABOVE ?

NCPIE, Copyright 2007 Whats In Play? VARIATIONS OF THE ABOVE?

NCPIE, Copyright 2007 Are We Overlooking Something? t Are We Overlooking Something? (Code: Webdings, Wingdings, Bookshelf Symbol 7, Arial)

NCPIE, Copyright 2007 Are We Overlooking Something? Telling consumers to read it & heed it and to ask questions ensures communication of useful medicine information … Right? What if you cant read, or cant read with understanding or dont speak the language of your health care provider?

NCPIE, Copyright 2007 Low Health Literacy Half of all adults are unable to understand much of what they need to know to take care of themselves and to follow their doctors instructions. (Dr. Harvey V. Fineberg, President, IOM) 90 million adults (1 in 3) may lack the functional reading and math skills to effectively use the U.S. health system; most are native born, English speakers. (Health Literacy: A Prescription to End Confusion, IOM)

NCPIE, Copyright 2007 Low Health Literacy Most likely to face limited health literacy: –Elderly; –Poor; –New Immigrants. System problem not a patient characteristic.

NCPIE, Copyright 2007 Three Approaches Showing Promise 1.Culturally appropriate health education 2.Patient advocacy 3.Medical education recognizing the critical importance of patient communication in the training of hcps at all levels. (IOM: Health Literacy: A Prescription to End Confusion, 2004)

NCPIE, Copyright 2007 Healthy People 2010 – Chapter 17 Federal goals for ensuring better (more useful) medicine communication: FDA is lead agency for monitoring progress to meet objectives in Chapter 17: Medical Product Safety. Objectives of relevance here:

NCPIE, Copyright 2007 Healthy People 2010 – Chapter Increase the proportion of primary care providers, pharmacists, and other hcps who routinely review with their patients aged 65 years & older and patients with chronic illnesses or disabilities all new prescribed & OTC medicines. DELETED from HP mid-course review!

NCPIE, Copyright 2007 Healthy People Chapter : Increase the proportion of patients receiving, at the time their new prescriptions are dispensed, written information that conforms to the Action Plan for the Provision of Prescription Medicine Information.

NCPIE, Copyright 2007 Healthy People 2010 – Chapter : Increase the proportion of patients receiving from prescribers, pharmacists, and other hcps oral counseling information that conveys directions for use and risk information (precautions and warnings).

NCPIE, Copyright 2007 Important – but Under-spoken - Aspect of Medicine Communication Medication counseling by: Prescribers and Pharmacists

NCPIE, Copyright 2007 Consumers Reported Receipt of Rx the Physicians Office (told selected info) How much to take: 55% 62% 64% How often to take:56% 64% 66% Refills: 32% 37% 37% Precautions: 33% 36% 37% Side Effects: 29% 35%35% Any information:61% 68%70% All information:n/a 24%26% (source: FDA; Dec. 2006)

NCPIE, Copyright 2007 Consumers Reported Receipt of Rx the Pharmacy (told selected info) How much to take: 28% 34% 29% How often to take:27% 34% 31% Refills: 16% 17% 16% Precautions: 18% 24% 21% Side Effects: 11% 20%17% Any information:37% 37%38% All information:n/a 12%6% (source: FDA; Dec. 2006)

NCPIE, Copyright 2007 Whats Likely to Change The Status Quo

NCPIE, Copyright 2007 In the (very) Near Future FDA Public Hearings: – Electronic dissemination of Package Insert (PI) April 27 in DC –Medication Guides (electronic dissemination, integration of content with CMI, etc) – June in DC

NCPIE, Copyright 2007 What Were All Seeking Provision of the most useful information for all consumers to promote safe and appropriate medicine use.

NCPIE, Copyright 2007 Questions

Contact Information Wm. Ray Bullman Executive Vice President National Council on Patient Information and Education 4915 Saint Elmo Ave., Suite 505 Bethesda, MD – (301) – phone (301) – fax